What is CorMedix's amortization of financing costs?

CorMedix (CRMD) reported amortization of financing costs of $99.5K in Q4 2025.

What does amortization of financing costs mean?

The periodic allocation of costs incurred to secure debt financing over the life of the associated debt instrument. This metric reflects the non-cash expense recognized as debt issuance costs are systematically expensed, impacting the effective interest rate of the company's borrowings.

CorMedix CRMD Amortization Of Financing Costs

Amortization Of Financing Costs at other companies

Medline, Inc. MDLN

$11M-26.7%

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's amortization of financing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's amortization of financing costs?: CorMedix (CRMD) reported amortization of financing costs of $99.5K in Q4 2025.
What does amortization of financing costs mean?: The periodic allocation of costs incurred to secure debt financing over the life of the associated debt instrument. This metric reflects the non-cash expense recognized as debt issuance costs are systematically expensed, impacting the effective interest rate of the company's borrowings.